Meclizine and Febuxostat drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Meclizine (meclizine hydrochloride) and Febuxostat (febuxostat). Common drug interactions include fall among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Meclizine and Febuxostat. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.
What is Meclizine?
Meclizine has active ingredients of meclizine hydrochloride. It is often used in dizziness. eHealthMe is studying from 23,116 Meclizine users. Check the latest studies of Meclizine.
What is Febuxostat?
Febuxostat has active ingredients of febuxostat. eHealthMe is studying from 9,693 Febuxostat users. Check the latest studies of Febuxostat.
23 people who take Meclizine and Febuxostat together, and have interactions are studied.

What are the common drug interactions of Meclizine and Febuxostat, by gender? *:
female:
- Fall
- Heart rate increased
- Infection
- Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
- Blood magnesium decreased
- Blood potassium decreased
- Bradykinesia (decreased bodily movement. it is associated with basal ganglia diseases)
- Cellulitis (infection under the skin)
- Contusion (a type of hematoma of tissue in which capillaries)
- Feeling hot
male:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Hepatic enzyme increased
- Nephropathy (damage to or disease of a kidney)
- Oedema (fluid collection in tissue)
- Oedema peripheral (superficial swelling)
- Pruritus (severe itching of the skin)
- Rib fracture
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Vomiting
What are the common drug interactions of Meclizine and Febuxostat, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Nephropathy (damage to or disease of a kidney)
40-49:
n/a
50-59:
- Blood magnesium decreased
- Blood potassium decreased
- Bradykinesia (decreased bodily movement. it is associated with basal ganglia diseases)
- Cellulitis (infection under the skin)
- Contusion (a type of hematoma of tissue in which capillaries)
- Fall
- Feeling hot
- Gait disturbance
- Heart rate increased
- Hypoaesthesia (reduced sense of touch or sensation)
60+:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Dyspnoea (difficult or laboured respiration)
- Fall
- Haemorrhage intracranial (bleeding within the skull)
- Head injury
- Heart rate irregular
- Hepatic enzyme increased
- Infusion site bruising
- Infusion site erythema (reddening of the skin at infusion site)
What are the existing conditions these people have? *
- High Blood Pressure: 8 people, 34.78%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 26.09%
- Insomnia (sleeplessness): 5 people, 21.74%
- Gout (uric acid crystals building up in the body): 5 people, 21.74%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 17.39%
- High Blood Cholesterol: 4 people, 17.39%
- Pain: 4 people, 17.39%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 17.39%
- Joint Pain: 3 people, 13.04%
- Cardiac Failure Congestive: 3 people, 13.04%
* Approximation only. Some reports may have incomplete information.
Do you take Meclizine and Febuxostat?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Meclizine (23,116 reports)
- Febuxostat (9,693 reports)
Browse all drug interactions of Meclizine and Febuxostat:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Meclizine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Febuxostat:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Meclizine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Febuxostat and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Hassan JK, "POTENTIAL POSITIVE EFFECT OF ORAL PYRIDOXINE ALONE AND IN COMBINATION WITH MECLIZINE ON CIGARETTES SMOKING DURING TENDAYS’TRIAL", IJPSR, 2015 Jan .
- Hassan JK, "POTENTIAL POSITIVE EFFECT OF ORAL PYRIDOXINE ALONE AND IN COMBINATION WITH MECLIZINE ON CIGARETTES SMOKING DURING TENDAYS’TRIAL", IJPSR, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on meclizine hydrochloride and febuxostat (the active ingredients of Meclizine and Febuxostat, respectively), and Meclizine and Febuxostat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Alphagan and Diovan - 3 seconds ago
- Could Albuterol Sulfate cause Menopausal Symptoms? - 4 seconds ago
- Drug interactions of Tegretol and Sutent - 4 seconds ago
- Drug interactions of Colace and Cobalamin - 8 seconds ago
- Drug interactions of Hydromorphone Hydrochloride and Almotriptan Malate - 12 seconds ago
- Could Akynzeo cause Indigestion? - 23 seconds ago
- Could Gentamicin cause Ventricular Hypertrophy? - 23 seconds ago
- Could Oracort cause Erythema Multiforme? - 25 seconds ago
- Could Combivent cause Mobility Decreased? - 37 seconds ago
- Could Zetia cause Joint Pain? - 37 seconds ago